BioCryst Pharmaceuticals
BCRX
#5073
Rank
โ‚น143.56 B
Marketcap
โ‚น681.86
Share price
-3.07%
Change (1 day)
5.83%
Change (1 year)

Market capitalization of BioCryst Pharmaceuticals (BCRX)

Market cap: โ‚น143.56 Billion

As of December 2025 BioCryst Pharmaceuticals has a market cap of โ‚น143.56 Billion. This makes BioCryst Pharmaceuticals the world's 5073th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioCryst Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น143.56 B4.79%
2024โ‚น137.00 B34.14%
2023โ‚น102.13 B-42.33%
2022โ‚น177.09 B-4.53%
2021โ‚น185.49 B92.82%
2020โ‚น96.20 B153.78%
2019โ‚น37.90 B-38.96%
2018โ‚น62.10 B101.31%
2017โ‚น30.85 B-2.76%
2016โ‚น31.72 B-36.93%
2015โ‚น50.30 B-9.28%
2014โ‚น55.45 B99.87%
2013โ‚น27.74 B601.19%
2012โ‚น3.95 B-33.02%
2011โ‚น5.90 B-43.28%
2010โ‚น10.41 B-20.86%
2009โ‚น13.16 B422.41%
2008โ‚น2.51 B-72.64%
2007โ‚น9.20 B-38.51%
2006โ‚น14.97 B-31.05%
2005โ‚น21.71 B298.75%
2004โ‚น5.44 B-2.28%
2003โ‚น5.57 B585.68%
2002โ‚น0.81 B-75.84%
2001โ‚น3.36 B-37.96%
2000โ‚น5.42 B-75.51%
1999โ‚น22.14 B397.23%
1998โ‚น4.45 B17.14%
1997โ‚น3.80 B-52.86%
1996โ‚น8.06 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of BioCryst Pharmaceuticals was reported to be:

โ‚น143.56 Billion
by Nasdaq info icon info icon
โ‚น143.56 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
โ‚น834.29 B 481.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น209.54 B 45.97%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น1.98 B-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น100.87 B-29.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น13.512 T 9,312.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น175.80 B 22.46%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น8.778 T 6,014.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
โ‚น57.03 B-60.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น4.63 B-96.77%๐Ÿ‡บ๐Ÿ‡ธ USA